A detailed history of Deutsche Bank Ag\ transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 10,849 shares of IGMS stock, worth $187,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,849
Previous 5,547 95.58%
Holding current value
$187,253
Previous $53,000 39.62%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.51 - $11.47 $34,516 - $60,813
5,302 Added 95.58%
10,849 $74,000
Q1 2024

May 15, 2024

SELL
$8.68 - $17.36 $53,425 - $106,850
-6,155 Reduced 52.6%
5,547 $53,000
Q4 2023

Feb 14, 2024

BUY
$3.94 - $8.79 $46,105 - $102,860
11,702 New
11,702 $97,000
Q2 2023

Aug 14, 2023

SELL
$8.86 - $14.0 $19,119 - $30,212
-2,158 Reduced 30.3%
4,965 $45,000
Q1 2023

May 15, 2023

BUY
$13.74 - $25.76 $24,663 - $46,239
1,795 Added 33.69%
7,123 $97,000
Q4 2022

Feb 13, 2023

SELL
$15.45 - $26.02 $68,505 - $115,372
-4,434 Reduced 45.42%
5,328 $90,000
Q3 2022

Nov 14, 2022

BUY
$15.42 - $27.01 $59,212 - $103,718
3,840 Added 64.84%
9,762 $222,000
Q2 2022

Aug 11, 2022

BUY
$13.27 - $25.5 $15,658 - $30,090
1,180 Added 24.88%
5,922 $107,000
Q1 2022

May 13, 2022

SELL
$13.42 - $29.73 $6,535 - $14,478
-487 Reduced 9.31%
4,742 $127,000
Q4 2021

Feb 11, 2022

BUY
$27.59 - $66.39 $7,173 - $17,261
260 Added 5.23%
5,229 $154,000
Q3 2021

Nov 04, 2021

SELL
$65.76 - $90.65 $10,521 - $14,504
-160 Reduced 3.12%
4,969 $327,000
Q2 2021

Aug 11, 2021

BUY
$57.98 - $96.6 $14,842 - $24,729
256 Added 5.25%
5,129 $426,000
Q1 2021

May 13, 2021

SELL
$71.56 - $121.23 $302,054 - $511,711
-4,221 Reduced 46.42%
4,873 $373,000
Q4 2020

Feb 16, 2021

BUY
$47.41 - $115.03 $244,730 - $593,784
5,162 Added 131.28%
9,094 $803,000
Q3 2020

Nov 12, 2020

SELL
$43.0 - $84.01 $10,535 - $20,582
-245 Reduced 5.87%
3,932 $290,000
Q2 2020

Aug 13, 2020

BUY
$51.3 - $75.21 $124,197 - $182,083
2,421 Added 137.87%
4,177 $304,000
Q1 2020

May 14, 2020

SELL
$31.51 - $73.75 $2,331 - $5,457
-74 Reduced 4.04%
1,756 $98,000
Q4 2019

Feb 14, 2020

BUY
$17.25 - $49.51 $31,567 - $90,603
1,830 New
1,830 $69,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.